HORIZON (OP-106): Melflufen plus dexamethasone in relapsed/refractory multiple myeloma (RRMM) refractory to pomalidomide and/or an anti-CD38 monoclonal antibody - Primary and subgroup analysis Meeting Abstract
| Authors: | Richardson, P.; Oriol, A.; Larocca, A.; Blade, J.; Cavo, M.; Rodriguez-Otero, P.; Leleu, X.; Norkin, M.; Nadeem, O.; Hiemenz, J.; Hassoun, H.; Touzeau, C.; Alegre, A.; Paner, A.; Maisel, C.; Mazumder, A.; Raptis, A.; Puig, N.; Byrne, C.; Mateos, M. V. |
| Abstract Title: | HORIZON (OP-106): Melflufen plus dexamethasone in relapsed/refractory multiple myeloma (RRMM) refractory to pomalidomide and/or an anti-CD38 monoclonal antibody - Primary and subgroup analysis |
| Meeting Title: | 2020 Lymphoma, Leukemia and Myeloma Congress |
| Journal Title: | American Journal of Hematology |
| Volume: | 95 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Oct 20-24 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0361-8609 |
| Publisher: | John Wiley & Sons, Inc. |
| Date Published: | 2020-10-01 |
| Start Page: | S27 |
| End Page: | S28 |
| Language: | English |
| ACCESSION: | WOS:000577607300034 |
| PROVIDER: | Clarivate Analytics Web of Science |
| PROVIDER: | wos |
| PUBMED: | 33058308 |
| DOI: | 10.1002/ajh.26005 |
| Notes: | Meeting Abstract: P-33 -- Source: Wos |
